These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25470867)

  • 1. Cryptogenic cirrhosis and NASH: entities in evolution and involution.
    Mahiuddin Ahammed SK; Chowdhury A
    Trop Gastroenterol; 2014; 35(2):65-70. PubMed ID: 25470867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is cryptogenic cirrhosis different from NASH cirrhosis?
    Thuluvath PJ; Kantsevoy S; Thuluvath AJ; Savva Y
    J Hepatol; 2018 Mar; 68(3):519-525. PubMed ID: 29162389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants.
    O'Leary JG; Landaverde C; Jennings L; Goldstein RM; Davis GL
    Clin Gastroenterol Hepatol; 2011 Aug; 9(8):700-704.e1. PubMed ID: 21570483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for nonalcoholic steatohepatitis in cryptogenic cirrhosis.
    Leite AB; Mattos AA; Mattos AZ; Coral GP; Evaldt S
    Arq Gastroenterol; 2012 Dec; 49(4):245-9. PubMed ID: 23329217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
    Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
    Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.
    Bugianesi E; Leone N; Vanni E; Marchesini G; Brunello F; Carucci P; Musso A; De Paolis P; Capussotti L; Salizzoni M; Rizzetto M
    Gastroenterology; 2002 Jul; 123(1):134-40. PubMed ID: 12105842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
    Caldwell SH; Oelsner DH; Iezzoni JC; Hespenheide EE; Battle EH; Driscoll CJ
    Hepatology; 1999 Mar; 29(3):664-9. PubMed ID: 10051466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NASH and cryptogenic cirrhosis: a histological analysis.
    Caldwell SH; Lee VD; Kleiner DE; Al-Osaimi AM; Argo CK; Northup PG; Berg CL
    Ann Hepatol; 2009; 8(4):346-52. PubMed ID: 20009134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis.
    Thuluvath PJ; Hanish S; Savva Y
    Transplantation; 2018 Apr; 102(4):656-663. PubMed ID: 29215462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptogenic cirrhosis: a vanishing entity.
    Desai HG
    J Assoc Physicians India; 2009 Nov; 57():751-4, 759. PubMed ID: 20329442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?
    Duclos-Vallée JC; Yilmaz F; Johanet C; Roque-Afonso AM; Gigou M; Trichet C; Féray C; Ballot E; Dussaix E; Castaing D; Bismuth H; Samuel D; Guettier C
    Clin Transplant; 2005 Oct; 19(5):591-9. PubMed ID: 16146549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
    Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
    Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
    Thuluvath PJ; Hanish S; Savva Y
    Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.
    Heringlake S; Schütte A; Flemming P; Schmiegel W; Manns MP; Tillmann HL
    Z Gastroenterol; 2009 May; 47(5):417-23. PubMed ID: 19418409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBsAg clearance in chronic active hepatitis B. A possible cause of cryptogenic cirrhosis.
    Morgan TR; Redeker AG; Yamada S; Ashcavai M
    Dig Dis Sci; 1986 Jul; 31(7):700-4. PubMed ID: 3720466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation and prevalence of spontaneous bacterial peritonitis in patients with cryptogenic cirrhosis and features of metabolic syndrome.
    Sorrentino P; Tarantino G; Conca P; Perrella A; Perrella O
    Can J Gastroenterol; 2004 Jun; 18(6):381-6. PubMed ID: 15190393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.
    Poonawala A; Nair SP; Thuluvath PJ
    Hepatology; 2000 Oct; 32(4 Pt 1):689-92. PubMed ID: 11003611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
    Farrell GC; Larter CZ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.